Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Recruiting · NCT05239624 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urothelial carcinoma | Recruiting | Phase 2 | 2026-09-17 | NCT05239624 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Astellas Pharma US, Inc. | 8 |
| Memorial Sloan Kettering Cancer Center | 753 |
| Merck Sharp & Dohme LLC | 650 |
| Seagen Inc. | 31 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baptist Alliance MCI | Miami | United States | 6 |
| Lehigh Valley Health Network (Data Collection Only) | Allentown | United States | 7 |
| Memorial Sloan Kettering -Nassau | Commack | United States | 1 |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | United States | 189 |
| Memorial Sloan Kettering Bergen | Montvale | United States | 193 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Memorial Sloan Kettering Monmouth | Middletown | United States | 206 |
| Memorial Sloan Kettering Nassau | Rockville Centre | United States | 9 |
| Memorial Sloan Kettering Westchester | Harrison | United States | 204 |
| University of Texas Southwestern Medical Center at Dallas | Dallas | United States | 10 |